Who owns Adverum Biotechnologies, Inc.?
- Ticker: ADVM
- CUSIP Number: 00773u207
Tip: Access positions for across all investors
Analyze quarterly positions in Adverum Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Adverum Biotechnologies stock
Who bought or sold Adverum Biotechnologies, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 3.1M | $14M | 0% | Sep 2025 |
|
| Frazier Life Sciences Management | 2.1M | $9.4M | 94% | Sep 2025 |
|
| Principia Wealth Advisory | 2.0M | $4.4M | 20% | Jun 2025 |
|
| TCG Crossover Management | 1.7M | $7.6M | -7% | Sep 2025 |
|
| Vanguard Group | 872k | $4.0M | -1% | Sep 2025 |
|
| 5AM Venture Management | 542k | $2.5M | 0% | Sep 2025 |
|
| Goldman Sachs Group | 403k | $1.8M | -13% | Sep 2025 |
|
| Renaissance Technologies | 364k | $1.6M | -36% | Sep 2025 |
|
| Pale Fire Capital SE | 363k | $1.6M | 1% | Sep 2025 |
|
| Millennium Management | 324k | $1.5M | -5% | Sep 2025 |
|
| BlackRock | 311k | $1.4M | -25% | Sep 2025 |
|
| Soleus Capital Management | 287k | $1.3M | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 235k | $1.1M | -18% | Sep 2025 |
|
| Geode Capital Management | 185k | $837k | 0% | Sep 2025 |
|
| Regeneron Pharmaceuticals | 181k | $820k | 0% | Sep 2025 |
|
| Warren Averett Asset Management | 161k | $729k | 0% | Sep 2025 |
|
| Two Sigma Investments | 89k | $402k | 373% | Sep 2025 |
|
| State Street Corporation | 69k | $311k | 0% | Sep 2025 |
|
| Susquehanna International | 58k | $260k | -3% | Sep 2025 |
|
| Morgan Stanley | 53k | $114k | 100% | Jun 2025 |
|
| Quinn Opportunity Partners | 41k | $188k | 0% | Sep 2025 |
|
| Citadel Advisors | 41k | $187k | -47% | Sep 2025 |
|
| Two Sigma Advisers | 38k | $173k | 256% | Sep 2025 |
|
| Marshall Wace | 28k | $129k | -43% | Sep 2025 |
|
| Northern Trust | 28k | $127k | -18% | Sep 2025 |
|
| Qube Research & Technologies | 22k | $98k | -29% | Sep 2025 |
|
| D. E. Shaw & Co | 17k | $78k | -36% | Sep 2025 |
|
| Royal Bank of Canada | 14k | $50k | 386% | Sep 2025 |
|
| JustInvest | 13k | $58k | 100% | Sep 2025 |
|
| XTX Topco | 13k | $57k | -57% | Sep 2025 |
|
| Squarepoint Ops | 11k | $51k | -48% | Sep 2025 |
|
| UBS Group | 5.6k | $25k | -61% | Sep 2025 |
|
| FMR | 1.9k | $8.8k | -17% | Sep 2025 |
|
| Advisor Group Holdings | 1.7k | $7.7k | 0% | Sep 2025 |
|
| Jones Financial Companies, L.L | 1.0k | $4.5k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 540.00 | $2.4k | -31% | Sep 2025 |
|
| UMA Financial Services | 217.00 | $984.008200 | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 182.00 | $824.005000 | -98% | Sep 2025 |
|
| Hanson McClain Advisors | 102.00 | $462.998400 | 0% | Sep 2025 |
|
| SBI Securities | 84.00 | $380.998800 | 0% | Sep 2025 |
|
| Parallel Advisors | 50.00 | $227.000000 | 0% | Sep 2025 |
|
| CWM | 33.00 | $0 | -98% | Sep 2025 |
|
| Wells Fargo & Company | 30.00 | $135.999000 | -86% | Sep 2025 |
|
| Barclays | 21.00 | $95.999400 | 100% | Sep 2025 |
|
| GHP Investment Advisors | 20.00 | $91.000000 | 0% | Sep 2025 |
|
| SRS Capital Advisors | 19.00 | $85.999700 | 100% | Sep 2025 |
|
| Sound Income Strategies | 1.00 | $5.000000 | 100% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 1.00 | $5.000000 | 0% | Sep 2025 |
|
Who sold out of Adverum Biotechnologies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Jun 2025 | 71k | $153k |
| Readystate Asset Management | Jun 2025 | 68k | $145k |
| Hrt Financial | Jun 2025 | 31k | $65k |
| Jain Global | Jun 2025 | 22k | $47k |
| Y-Intercept | Jun 2025 | 21k | $45k |
| Point72 Asia | Jun 2025 | 15k | $31k |
| American Century Companies | Jun 2025 | 11k | $23k |
| Captrust Financial Advisors | Jun 2025 | 10k | $22k |
| Tower Research Capital | Jun 2025 | 2.1k | $4.6k |
| Cubist Systematic Strategies | Jun 2025 | 1.9k | $4.1k |
| Raymond James Financial | Jun 2025 | 1.0k | $2.2k |
| Point72 | Jun 2025 | 225.00 | $483.997500 |
| Eq Wealth Advisors | Jun 2025 | 162.00 | $347.992200 |
| NISA Investment Advisors | Jun 2025 | 84.00 | $181.003200 |